{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:14:41Z","timestamp":1795133681107,"version":"4.10.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bisphosphonates are frequently used for the antiresorptive treatment in bone metastasis diseases or for osteoporosis. A side effect of this therapy is osteonecrosis of the jaw. This inhibits osteoclast function, but osteoblasts and fibroblasts are also negatively affected in terms of impaired proliferation. Additive local treatment with platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) promotes adhesion, proliferation and migration of cells due to high concentrations of growth factors like PDGF, TGF and IGF. The aim of the study was to investigate the effect of PRP or PRF on proliferation, migration and viability of osteoblasts and oral fibroblasts, treated with zoledronic acid (ZA). ZA treated fibroblasts and osteoblasts were exposed to PRP\/PRF. Cell proliferation, migration and viability were measured using the real-time cell-analyzer assay (RTCA), the scratch assay and the MTT assay. There was a significant increase in closure of the scratch area by PRP\/PRF treated osteoblasts (PRP\u2009=\u200940.6%, PRF\u2009=\u2009100.0%, NC\u2009=\u20090.0%) as well as fibroblasts (PRP\u2009=\u2009100.0%, PRF\u2009=\u2009100.0%, NC\u2009=\u200912.7%) in comparison to the group of negative control (all <jats:italic>p<\/jats:italic>\u2009\u2264\u2009<jats:italic>0<\/jats:italic>.<jats:italic>05<\/jats:italic>). Furthermore, the negative effect of ZA on cell migration was generally reduced in both cell lines using PRP\/PRF. The viability and proliferation of cells decreased after exposure to ZA, whereas we observed an enhancement of cell viability within 24\u2009hours by application of PRP\/PRF in ZA treated cells. The negative effect of ZA on cell proliferation was especially reduced when using PRF. The use of PRF\/PRP improves the behavior of ZA-treated cells, but PRF appears to have an advantage in comparison to PRP. This study demonstrates that treatment with PRF\/PRP may have positive effects in the therapy of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).<\/jats:p>","DOI":"10.1038\/s41598-019-43798-z","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T10:03:07Z","timestamp":1559728987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9145-9308","authenticated-orcid":false,"given":"Daniel","family":"Steller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Pries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer G.","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"43798_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/1477-3163.75723","volume":"10","author":"H Almubarak","year":"2011","unstructured":"Almubarak, H. et al. Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers. J Carcinog 10, 2, https:\/\/doi.org\/10.4103\/1477-3163.75723 (2011).","journal-title":"J Carcinog"},{"key":"43798_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/sj.bjc.6605604","volume":"102","author":"RE Coleman","year":"2010","unstructured":"Coleman, R. E. et al. The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. Br J Cancer 102, 1099\u20131105, https:\/\/doi.org\/10.1038\/sj.bjc.6605604 (2010).","journal-title":"Br J Cancer"},{"key":"43798_CR3","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/S0149-2918(03)80327-2","volume":"25","author":"EC Li","year":"2003","unstructured":"Li, E. C. & Davis, L. E. Zoledronic acid: a new parenteral bisphosphonate. Clin Ther 25, 2669\u20132708 (2003).","journal-title":"Clin Ther"},{"key":"43798_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3109\/00365590903295193","volume":"43","author":"A Haidar","year":"2009","unstructured":"Haidar, A., Jonler, M., Folkmar, T. B. & Lund, L. Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw. Scand J Urol Nephrol 43, 442\u2013444, https:\/\/doi.org\/10.3109\/00365590903295193 (2009).","journal-title":"Scand J Urol Nephrol"},{"key":"43798_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","volume":"65","author":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws.","year":"2007","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 65, 369\u2013376, https:\/\/doi.org\/10.1016\/j.joms.2006.11.003 (2007).","journal-title":"J Oral Maxillofac Surg"},{"key":"43798_CR6","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias, A. et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23, 8580\u20138587, https:\/\/doi.org\/10.1200\/JCO.2005.02.8670 (2005).","journal-title":"J Clin Oncol"},{"key":"43798_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","volume":"44","author":"T Boonyapakorn","year":"2008","unstructured":"Boonyapakorn, T., Schirmer, I., Reichart, P. A., Sturm, I. & Massenkeil, G. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44, 857\u2013869, https:\/\/doi.org\/10.1016\/j.oraloncology.2007.11.012 (2008).","journal-title":"Oral Oncol"},{"key":"43798_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1746-160X-6-11","volume":"6","author":"C Walter","year":"2010","unstructured":"Walter, C. et al. Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head Face Med 6, 11, https:\/\/doi.org\/10.1186\/1746-160X-6-11 (2010).","journal-title":"Head Face Med"},{"key":"43798_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1601-0825.2010.01720.x","volume":"17","author":"C Walter","year":"2011","unstructured":"Walter, C., Pabst, A., Ziebart, T., Klein, M. & Al-Nawas, B. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro. Oral Dis 17, 194\u2013199, https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01720.x (2011).","journal-title":"Oral Dis"},{"key":"43798_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/00016357.2016.1217041","volume":"74","author":"TB Kruger","year":"2016","unstructured":"Kruger, T. B., Herlofson, B. B., Landin, M. A. & Reseland, J. E. Alendronate alters osteoblast activities. Acta Odontol Scand 74, 550\u2013557, https:\/\/doi.org\/10.1080\/00016357.2016.1217041 (2016).","journal-title":"Acta Odontol Scand"},{"key":"43798_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.archoralbio.2010.11.003","volume":"56","author":"MJ Ravosa","year":"2011","unstructured":"Ravosa, M. J., Ning, J., Liu, Y. & Stack, M. S. Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts. Arch Oral Biol 56, 491\u2013498, https:\/\/doi.org\/10.1016\/j.archoralbio.2010.11.003 (2011).","journal-title":"Arch Oral Biol"},{"key":"43798_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00520-009-0688-1","volume":"18","author":"P Stockmann","year":"2010","unstructured":"Stockmann, P. et al. Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer 18, 449\u2013460, https:\/\/doi.org\/10.1007\/s00520-009-0688-1 (2010).","journal-title":"Support Care Cancer"},{"key":"43798_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00520-006-0120-z","volume":"15","author":"C Walter","year":"2007","unstructured":"Walter, C., Grotz, K. A., Kunkel, M. & Al-Nawas, B. Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 15, 197\u2013202, https:\/\/doi.org\/10.1007\/s00520-006-0120-z (2007).","journal-title":"Support Care Cancer"},{"key":"43798_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","volume":"138","author":"MC Adornato","year":"2007","unstructured":"Adornato, M. C., Morcos, I. & Rozanski, J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 138, 971\u2013977 (2007).","journal-title":"J Am Dent Assoc"},{"key":"43798_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00001665-200503000-00015","volume":"16","author":"JD Kassolis","year":"2005","unstructured":"Kassolis, J. D. & Reynolds, M. A. Evaluation of the adjunctive benefits of platelet-rich plasma in subantral sinus augmentation. J Craniofac Surg 16, 280\u2013287 (2005).","journal-title":"J Craniofac Surg"},{"key":"43798_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1600-0501.2008.01525.x","volume":"19","author":"AS Plachokova","year":"2008","unstructured":"Plachokova, A. S., Nikolidakis, D., Mulder, J., Jansen, J. A. & Creugers, N. H. Effect of platelet-rich plasma on bone regeneration in dentistry: a systematic review. Clin Oral Implants Res 19, 539\u2013545, https:\/\/doi.org\/10.1111\/j.1600-0501.2008.01525.x (2008).","journal-title":"Clin Oral Implants Res"},{"key":"43798_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/jcb.20219","volume":"93","author":"J Fiedler","year":"2004","unstructured":"Fiedler, J., Etzel, N. & Brenner, R. E. To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93, 990\u2013998, https:\/\/doi.org\/10.1002\/jcb.20219 (2004).","journal-title":"J Cell Biochem"},{"key":"43798_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.injury.2011.03.055","volume":"42","author":"K Sarahrudi","year":"2011","unstructured":"Sarahrudi, K. et al. Elevated transforming growth factor-beta 1 (TGF-beta1) levels in human fracture healing. Injury 42, 833\u2013837, https:\/\/doi.org\/10.1016\/j.injury.2011.03.055 (2011).","journal-title":"Injury"},{"key":"43798_CR19","doi-asserted-by":"publisher","first-page":"9656","DOI":"10.1073\/pnas.152324099","volume":"99","author":"J Street","year":"2002","unstructured":"Street, J. et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656\u20139661, https:\/\/doi.org\/10.1073\/pnas.152324099 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"43798_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2018.10.017","author":"D Steller","year":"2018","unstructured":"Steller, D., Herbst, N., Pries, R., Juhl, D. & Hakim, S. G. Impact of incubation method on the release of growth factors in non-Ca(2+)-activated PRP, Ca(2+)-activated PRP, PRF and A-PRF. J Craniomaxillofac Surg. https:\/\/doi.org\/10.1016\/j.jcms.2018.10.017 (2018).","journal-title":"J Craniomaxillofac Surg"},{"key":"43798_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ijom.2004.10.018","volume":"34","author":"BH Choi","year":"2005","unstructured":"Choi, B. H. et al. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg 34, 420\u2013424, https:\/\/doi.org\/10.1016\/j.ijom.2004.10.018 (2005).","journal-title":"Int J Oral Maxillofac Surg"},{"key":"43798_CR22","doi-asserted-by":"publisher","first-page":"16036","DOI":"10.1038\/boneres.2016.36","volume":"4","author":"G Fernandes","year":"2016","unstructured":"Fernandes, G. & Yang, S. Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering. Bone Res 4, 16036, https:\/\/doi.org\/10.1038\/boneres.2016.36 (2016).","journal-title":"Bone Res"},{"key":"43798_CR23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1089\/1076327041348284","volume":"10","author":"Y Yamada","year":"2004","unstructured":"Yamada, Y. et al. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10, 955\u2013964, https:\/\/doi.org\/10.1089\/1076327041348284 (2004).","journal-title":"Tissue Eng"},{"key":"43798_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jbm.a.32839","volume":"95","author":"IC Chang","year":"2010","unstructured":"Chang, I. C., Tsai, C. H. & Chang, Y. C. Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Mater Res A 95, 327\u2013332, https:\/\/doi.org\/10.1002\/jbm.a.32839 (2010).","journal-title":"J Biomed Mater Res A"},{"key":"43798_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.abb.2010.12.013","volume":"507","author":"S Morelli","year":"2011","unstructured":"Morelli, S. et al. Protein phosphatases: possible bisphosphonate binding sites mediating stimulation of osteoblast proliferation. Arch Biochem Biophys 507, 248\u2013253, https:\/\/doi.org\/10.1016\/j.abb.2010.12.013 (2011).","journal-title":"Arch Biochem Biophys"},{"key":"43798_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0030-5898(20)31576-5","volume":"21","author":"ME Joyce","year":"1990","unstructured":"Joyce, M. E., Jingushi, S. & Bolander, M. E. Transforming growth factor-beta in the regulation of fracture repair. Orthop Clin North Am 21, 199\u2013209 (1990).","journal-title":"Orthop Clin North Am"},{"key":"43798_CR27","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1359\/jbmr.080617","volume":"23","author":"LI Plotkin","year":"2008","unstructured":"Plotkin, L. I. et al. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J Bone Miner Res 23, 1712\u20131721, https:\/\/doi.org\/10.1359\/jbmr.080617 (2008).","journal-title":"J Bone Miner Res"},{"issue":"9","key":"43798_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/cells7090142","volume":"7","author":"Flaminia Chellini","year":"2018","unstructured":"Chellini, F. et al. Platelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-beta1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-A\/VEGF Receptor-1-Mediated Signaling (dagger). Cells 7, https:\/\/doi.org\/10.3390\/cells7090142 (2018).","journal-title":"Cells"},{"issue":"2","key":"43798_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/cancers11020206","volume":"11","author":"Rosa Scala","year":"2019","unstructured":"Scala, R. et al. Zoledronic Acid Modulation of TRPV1 Channel Currents in Osteoblast Cell Line and Native Rat and Mouse Bone Marrow-Derived Osteoblasts: Cell Proliferation and Mineralization Effect. Cancers (Basel) 11, https:\/\/doi.org\/10.3390\/cancers11020206 (2019).","journal-title":"Cancers"},{"key":"43798_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejmech.2018.08.044","volume":"158","author":"S Savino","year":"2018","unstructured":"Savino, S. et al. Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis. Eur J Med Chem 158, 184\u2013200, https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.044 (2018).","journal-title":"Eur J Med Chem"},{"key":"43798_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-017-0381-6","volume":"17","author":"E Kobayashi","year":"2017","unstructured":"Kobayashi, E. et al. Effects of platelet rich plasma (PRP) on human gingival fibroblast, osteoblast and periodontal ligament cell behaviour. BMC Oral Health 17, 91, https:\/\/doi.org\/10.1186\/s12903-017-0381-6 (2017).","journal-title":"BMC Oral Health"},{"issue":"2","key":"43798_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/ijms18020331","volume":"18","author":"Xuzhu Wang","year":"2017","unstructured":"Wang, X., Zhang, Y., Choukroun, J., Ghanaati, S. & Miron, R. J. Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP. Int J Mol Sci 18, https:\/\/doi.org\/10.3390\/ijms18020331 (2017).","journal-title":"International Journal of Molecular Sciences"},{"key":"43798_CR33","first-page":"121","volume":"3","author":"R Alissa","year":"2010","unstructured":"Alissa, R., Esposito, M., Horner, K. & Oliver, R. The influence of platelet-rich plasma on the healing of extraction sockets: an explorative randomised clinical trial. Eur J Oral Implantol 3, 121\u2013134 (2010).","journal-title":"Eur J Oral Implantol"},{"key":"43798_CR34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1902\/jop.2008.070395","volume":"79","author":"M Caceres","year":"2008","unstructured":"Caceres, M. et al. Effect of platelet-rich plasma on cell adhesion, cell migration, and myofibroblastic differentiation in human gingival fibroblasts. J Periodontol 79, 714\u2013720, https:\/\/doi.org\/10.1902\/jop.2008.070395 (2008).","journal-title":"J Periodontol"},{"key":"43798_CR35","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1600-0501.2011.02274.x","volume":"23","author":"M Caceres","year":"2012","unstructured":"Caceres, M., Martinez, C., Martinez, J. & Smith, P. C. Effects of platelet-rich and -poor plasma on the reparative response of gingival fibroblasts. Clin Oral Implants Res 23, 1104\u20131111, https:\/\/doi.org\/10.1111\/j.1600-0501.2011.02274.x (2012).","journal-title":"Clin Oral Implants Res"},{"key":"43798_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-015-0818-5","volume":"16","author":"KC Huang","year":"2015","unstructured":"Huang, K. C., Cheng, C. C., Chuang, P. Y. & Yang, T. Y. The effects of zoledronate on the survival and function of human osteoblast-like cells. BMC Musculoskelet Disord 16, 355, https:\/\/doi.org\/10.1186\/s12891-015-0818-5 (2015).","journal-title":"BMC Musculoskelet Disord"},{"key":"43798_CR37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.tripleo.2009.06.044","volume":"108","author":"L He","year":"2009","unstructured":"He, L., Lin, Y., Hu, X., Zhang, Y. & Wu, H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108, 707\u2013713, https:\/\/doi.org\/10.1016\/j.tripleo.2009.06.044 (2009).","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"43798_CR38","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1016\/j.biomaterials.2003.12.043","volume":"25","author":"KA Schlegel","year":"2004","unstructured":"Schlegel, K. A. et al. De novo bone formation using bovine collagen and platelet-rich plasma. Biomaterials 25, 5387\u20135393, https:\/\/doi.org\/10.1016\/j.biomaterials.2003.12.043 (2004).","journal-title":"Biomaterials"},{"key":"43798_CR39","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.biomaterials.2004.07.041","volume":"26","author":"M Thorwarth","year":"2005","unstructured":"Thorwarth, M. et al. Expression of bone matrix proteins during de novo bone formation using a bovine collagen and platelet-rich plasma (prp)\u2013an immunohistochemical analysis. Biomaterials 26, 2575\u20132584, https:\/\/doi.org\/10.1016\/j.biomaterials.2004.07.041 (2005).","journal-title":"Biomaterials"},{"key":"43798_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1524-475X.2007.00344.x","volume":"16","author":"R Lundquist","year":"2008","unstructured":"Lundquist, R., Dziegiel, M. H. & Agren, M. S. Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin. Wound Repair Regen 16, 356\u2013363, https:\/\/doi.org\/10.1111\/j.1524-475X.2007.00344.x (2008).","journal-title":"Wound Repair Regen"},{"key":"43798_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jbm.a.30147","volume":"71","author":"JM Karp","year":"2004","unstructured":"Karp, J. M., Sarraf, F., Shoichet, M. S. & Davies, J. E. Fibrin-filled scaffolds for bone-tissue engineering: An in vivo study. J Biomed Mater Res A 71, 162\u2013171, https:\/\/doi.org\/10.1002\/jbm.a.30147 (2004).","journal-title":"J Biomed Mater Res A"},{"key":"43798_CR42","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1537-2995.2008.02033.x","volume":"49","author":"I Giusti","year":"2009","unstructured":"Giusti, I. et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion 49, 771\u2013778, https:\/\/doi.org\/10.1111\/j.1537-2995.2008.02033.x (2009).","journal-title":"Transfusion"},{"key":"43798_CR43","first-page":"12","volume":"6","author":"A Rughetti","year":"2008","unstructured":"Rughetti, A. et al. Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells. Blood Transfus 6, 12\u201317 (2008).","journal-title":"Blood Transfus"},{"key":"43798_CR44","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1902\/jop.2007.070116","volume":"78","author":"J Uggeri","year":"2007","unstructured":"Uggeri, J. et al. Dose-dependent effects of platelet gel releasate on activities of human osteoblasts. J Periodontol 78, 1985\u20131991, https:\/\/doi.org\/10.1902\/jop.2007.070116 (2007).","journal-title":"J Periodontol"},{"key":"43798_CR45","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.tripleo.2009.04.020","volume":"108","author":"DM Dohan Ehrenfest","year":"2009","unstructured":"Dohan Ehrenfest, D. M. et al. In vitro effects of Choukroun\u2019s PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108, 341\u2013352, https:\/\/doi.org\/10.1016\/j.tripleo.2009.04.020 (2009).","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"43798_CR46","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1177\/0363546515608157","volume":"43","author":"JA Cross","year":"2015","unstructured":"Cross, J. A. et al. Leukocyte-Reduced Platelet-Rich Plasma Normalizes Matrix Metabolism in Torn Human Rotator Cuff Tendons. Am J Sports Med 43, 2898\u20132906, https:\/\/doi.org\/10.1177\/0363546515608157 (2015).","journal-title":"Am J Sports Med"},{"key":"43798_CR47","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2174\/138920112800624382","volume":"13","author":"DM Dohan Ehrenfest","year":"2012","unstructured":"Dohan Ehrenfest, D. M. et al. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 13, 1145\u20131152 (2012).","journal-title":"Curr Pharm Biotechnol"},{"key":"43798_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0825-9","volume":"14","author":"W Yin","year":"2016","unstructured":"Yin, W. et al. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects. J Transl Med 14, 73, https:\/\/doi.org\/10.1186\/s12967-016-0825-9 (2016).","journal-title":"J Transl Med"},{"key":"43798_CR49","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00167-011-1837-x","volume":"20","author":"G Filardo","year":"2012","unstructured":"Filardo, G. et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc 20, 2082\u20132091, https:\/\/doi.org\/10.1007\/s00167-011-1837-x (2012).","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"43798_CR50","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.3892\/etm.2018.5887","volume":"15","author":"I Giusti","year":"2018","unstructured":"Giusti, I. et al. Leukocyte depletion does not affect the in vitro healing ability of platelet rich plasma. Exp Ther Med 15, 4029\u20134038, https:\/\/doi.org\/10.3892\/etm.2018.5887 (2018).","journal-title":"Exp Ther Med"},{"key":"43798_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13287-015-0172-4","volume":"6","author":"Y Zhou","year":"2015","unstructured":"Zhou, Y., Zhang, J., Wu, H., Hogan, M. V. & Wang, J. H. The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem\/progenitor cells - implications of PRP application for the clinical treatment of tendon injuries. Stem Cell Res Ther 6, 173, https:\/\/doi.org\/10.1186\/s13287-015-0172-4 (2015).","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"43798_CR52","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00784-018-2349-6","volume":"22","author":"Junho Jung","year":"2018","unstructured":"Jung, J. et al. Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro. Clin Oral Investig, https:\/\/doi.org\/10.1007\/s00784-018-2349-6 (2018).","journal-title":"Clinical Oral Investigations"},{"key":"43798_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/09537104.2017.1293807","volume":"29","author":"X Wang","year":"2018","unstructured":"Wang, X., Zhang, Y., Choukroun, J., Ghanaati, S. & Miron, R. J. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets 29, 48\u201355, https:\/\/doi.org\/10.1080\/09537104.2017.1293807 (2018).","journal-title":"Platelets"},{"key":"43798_CR54","unstructured":"Bundesa\u0308rztekammer. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Ha\u0308motherapie) (2017)."},{"key":"43798_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/ten.TEB.2013.0317","volume":"20","author":"HT Liao","year":"2014","unstructured":"Liao, H. T., Marra, K. G. & Rubin, J. P. Application of platelet-rich plasma and platelet-rich fibrin in fat grafting: basic science and literature review. Tissue Eng Part B Rev 20, 267\u2013276, https:\/\/doi.org\/10.1089\/ten.TEB.2013.0317 (2014).","journal-title":"Tissue Eng Part B Rev"},{"key":"43798_CR56","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1089\/ten.TEA.2010.0663","volume":"17","author":"SA Sell","year":"2011","unstructured":"Sell, S. A., Wolfe, P. S., Ericksen, J. J., Simpson, D. G. & Bowlin, G. L. Incorporating platelet-rich plasma into electrospun scaffolds for tissue engineering applications. Tissue Eng Part A 17, 2723\u20132737, https:\/\/doi.org\/10.1089\/ten.TEA.2010.0663 (2011).","journal-title":"Tissue Eng Part A"},{"key":"43798_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1054\/jcms.2002.0285","volume":"30","author":"G Weibrich","year":"2002","unstructured":"Weibrich, G., Kleis, W. K., Hafner, G. & Hitzler, W. E. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30, 97\u2013102, https:\/\/doi.org\/10.1054\/jcms.2002.0285 (2002).","journal-title":"J Craniomaxillofac Surg"},{"key":"43798_CR58","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/trf.13998","volume":"57","author":"G Strandberg","year":"2017","unstructured":"Strandberg, G. et al. Standardizing the freeze-thaw preparation of growth factors from platelet lysate. Transfusion 57, 1058\u20131065, https:\/\/doi.org\/10.1111\/trf.13998 (2017).","journal-title":"Transfusion"},{"key":"43798_CR59","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00784-016-1719-1","volume":"20","author":"E Kobayashi","year":"2016","unstructured":"Kobayashi, E. et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig 20, 2353\u20132360, https:\/\/doi.org\/10.1007\/s00784-016-1719-1 (2016).","journal-title":"Clin Oral Investig"},{"key":"43798_CR60","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/ten.TEC.2011.0308","volume":"18","author":"J Araki","year":"2012","unstructured":"Araki, J. et al. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods 18, 176\u2013185, https:\/\/doi.org\/10.1089\/ten.TEC.2011.0308 (2012).","journal-title":"Tissue Eng Part C Methods"},{"key":"43798_CR61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jos.2016.07.009","volume":"21","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi, Y. et al. Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations. J Orthop Sci 21, 683\u2013689, https:\/\/doi.org\/10.1016\/j.jos.2016.07.009 (2016).","journal-title":"J Orthop Sci"},{"key":"43798_CR62","first-page":"873","volume":"28","author":"A Corrado","year":"2010","unstructured":"Corrado, A. et al. Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. Clin Exp Rheumatol 28, 873\u2013879 (2010).","journal-title":"Clin Exp Rheumatol"},{"key":"43798_CR63","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1177\/009127002762491316","volume":"42","author":"T Chen","year":"2002","unstructured":"Chen, T. et al. Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. J Clin Pharmacol 42, 1228\u20131236 (2002).","journal-title":"J Clin Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43798-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43798-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43798-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:19:24Z","timestamp":1671272364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43798-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43798"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43798-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8310"}}